Data / Form D filings / Sunflower Therapeutics, PBC
Sunflower Therapeutics, PBC: Form D filings
Sunflower Therapeutics, PBC, a biotechnology company in Hingham, MA, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on May 24, 2024, reports $2 million sold of a $3 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 18 Shipyard Dr., Ste. 2A, Hingham, MA, 02043
- Phone
- (781) 539-8100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1950773
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 24, 2024 | New notice | $3,000,000 | $2,030,000 | $970,000 | 2 | May 13, 2024 | sec.gov |
| Oct 14, 2022 | New notice | $1,500,000 | $610,000 | $890,000 | 8 | Sep 28, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Larry R. Weiner | Director | |
| J. Christopher R. Love | Director | |
| Maik R. Jornitz | Director | |
| Kerry R. Love | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 20, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sunflower Therapeutics, PBC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.